ACM
AMGN icon

Armbruster Capital Management’s Amgen AMGN Stock Holding History

Armbruster Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716K Sell
1,978
-3
-0.2% -$1.03K 0.11% 71
2026
Q1 		$697K Sell
1,981
-115
-5% -$41K 0.11% 73
2025
Q4 		$686K Sell
2,096
-165
-7% -$52.3K 0.12% 74
2025
Q3 		$638K Sell
2,261
-80
-3% -$23.2K 0.11% 77
2025
Q2 		$654K Hold
2,341
– – 0.12% 71
2025
Q1 		$729K Sell
2,341
-75
-3% -$22.1K 0.15% 65
2024
Q4 		$630K Sell
2,416
-56
-2% -$16.6K 0.13% 70
2024
Q3 		$797K Sell
2,472
-15
-0.6% -$4.91K 0.16% 64
2024
Q2 		$777K Buy
2,487
+72
+3% +$21.2K 0.16% 58
2024
Q1 		$687K Sell
2,415
-60
-2% -$17.6K 0.15% 56
2023
Q4 		$713K Hold
2,475
– – 0.16% 53
2023
Q3 		$665K Hold
2,475
– – 0.17% 54
2023
Q2 		$550K Hold
2,475
– – 0.14% 61
2023
Q1 		$598K Sell
2,475
-40
-2% -$9.82K 0.15% 55
2022
Q4 		$661K Hold
2,515
– – 0.17% 52
2022
Q3 		$567K Hold
2,515
– – 0.16% 58
2022
Q2 		$612K Sell
2,515
-75
-3% -$18.4K 0.17% 60
2022
Q1 		$626K Buy
2,590
+35
+1% +$8.04K 0.15% 61
2021
Q4 		$575K Hold
2,555
– – 0.13% 73
2021
Q3 		$543K Hold
2,555
– – 0.16% 53
2021
Q2 		$623K Hold
2,555
– – 0.18% 47
2021
Q1 		$636K Sell
2,555
-125
-5% -$29.8K 0.19% 42
2020
Q4 		$616K Hold
2,680
– – 0.21% 41
2020
Q3 		$681K Hold
2,680
– – 0.26% 39
2020
Q2 		$632K Hold
2,680
– – 0.25% 40
2020
Q1 		$543K Sell
2,680
-500
-16% -$109K 0.26% 41
2019
Q4 		$767K Hold
3,180
– – 0.29% 37
2019
Q3 		$615K Hold
3,180
– – 0.26% 38
2019
Q2 		$586K Sell
3,180
-140
-4% -$25.1K 0.25% 38
2019
Q1 		$631K Hold
3,320
– – 0.27% 37
2018
Q4 		$646K Hold
3,320
– – 0.32% 34
2018
Q3 		$688K Hold
3,320
– – 0.3% 36
2018
Q2 		$613K Sell
3,320
-320
-9% -$56.6K 0.29% 34
2018
Q1 		$621K Sell
3,640
-100
-3% -$18.4K 0.29% 33
2017
Q4 		$650K Sell
3,740
-100
-3% -$17.7K 0.3% 32
2017
Q3 		$716K Sell
3,840
-54
-1% -$9.57K 0.37% 27
2017
Q2 		$671K Buy
3,894
+554
+17% +$90.1K 0.36% 29
2017
Q1 		$548K Buy
3,340
+312
+10% +$51.8K 0.31% 33
2016
Q4 		$443K Hold
3,028
– – 0.26% 36
2016
Q3 		$505K Hold
3,028
– – 0.31% 32
2016
Q2 		$461K Hold
3,028
– – 0.3% 37
2016
Q1 		$454K Hold
3,028
– – 0.31% 36
2015
Q4 		$492K Buy
+3,028
New +$476K 0.44% 34

Other funds holding AMGN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Armbruster Capital Management's AMGN Position: Q2 2026 in Review

Armbruster Capital Management reduced its Amgen (AMGN) stake by 0.15% in Q2 2026, selling an estimated $1.03K and leaving 1,978 shares worth $716K. The position accounts for 0.11% of the portfolio, ranked #71.

Armbruster Capital Management first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $797K in Q3 2024. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Armbruster Capital Management held 1,978 shares of Amgen worth $716K as of Q2 2026.
  • Armbruster Capital Management sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.11% of Armbruster Capital Management's portfolio in Q2 2026, its #71 holding.
  • Armbruster Capital Management first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
  • Armbruster Capital Management's Amgen position peaked at $797K in Q3 2024.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Armbruster Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.